The stock market is waiting on a follow through day. Miami's eMerge Americas conference may provide some surprise energy for ...
Lucera, 57 years old, joins Dyne, a clinical-stage muscle disease company, from Editas Medicine, where he has served as CFO since May 2023, Dyne said Thursday. He has also held the top finance jobs at ...
Proven financial leader brings decades of experience in capital allocation, business development and shareholder value creation -WALTHAM, ...
A high throughput screen of >30,000 diverse repressor domains from across the tree of life identifies repressor domains with unique structures that underpin enhanced epigenetic effector domain ...
If you’ve had to cancel or change a United Airlines flight or have experienced any United operational issues, you’ve likely received a United travel credit. United Airlines issues two types of ...
Commissions do not affect our editors' opinions or evaluations. United Airlines (UA) is one of the world’s biggest airlines. Based out of Chicago, it operates 4,500 flights in over 300 ...
LGT Fund Management Co Ltd. acquired a new stake in United Therapeutics Co. (NASDAQ:UTHR – Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and ...
HC Wainwright reissued their buy rating on shares of United Therapeutics (NASDAQ:UTHR – Free Report) in a report published on Thursday morning,Benzinga reports. HC Wainwright currently has a $ ...
United Therapeutics stock opened at $319.96 on Thursday. United Therapeutics has a 12-month low of $221.53 and a 12-month high of $417.82. The company has a market capitalization of $14.28 billion ...
The United Nations is the world’s principal organization for deliberating matters of peace and security, but its work encompasses far more than peacekeeping and conflict prevention. The UN ...
2.11 % 2007-2025 Central Bank of the United Arab Emirates In the United Arab Emirates the interest rate decisions are taken by the Central Bank of the United Arab Emirates. The official interest ...
Leerink analyst Roanna Ruiz lowered the firm’s price target on United Therapeutics (UTHR) to $420 from $430 and keeps an Outperform rating on the shares. United Therapeutics’ Q4 earnings ...